Founded in 2019, Breakthrough Properties is a privately held life science real estate investment and development firm headquartered in Los Angeles. The company emerged as a joint venture between global real estate developer Tishman Speyer and biotechnology investment firm Bellco Capital. This partnership combines deep expertise in real estate and biotech to address the growing demand for specialized research and development facilities in the life sciences sector. Breakthrough Properties focuses on developing and operating high-performance lab and office environments tailored to the needs of biotech, pharmaceutical, and academic research organizations. Its investment strategy centers on acquiring and developing mission-critical assets in top-tier innovation markets, with a strong emphasis on sustainability, flexible design, and operational excellence. The firm manages over $2.5 billion in regulatory assets under management and has launched multiple private funds targeting value-add and income-producing life science assets.